Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The US-based cell and gene therapy tool producer has teamed up with Casdin Capital to launch a bioproduction accelerator having recently backed two biotech startups.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Morningside Ventures has led a $30m series A round for Emory University spinout Meissa Vaccines, a current resident in Johnson & Johnsons’ JLabs incubator.

Morningside Ventures has led a $30m series A round for Emory University spinout Meissa Vaccines, a current resident at Johnson & Johnsons’ JLabs incubator.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The gum disease vaccine developer has spun out of University of Melbourne with series A funding from investors including CSL.

Gum disease vaccine developer Denteric has spun out of Melbourne with series A capital from the institution, the Biomedical Translation Fund and CSL.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aprea Therapeutics, a Karolinska Institute spinout, is set to raise as much as $92m from an offering that would bank Karolinska Development a return of up to $8m.